Join us as we chat with Michel Michaelides, (BSc MB BS MD(Res) FRCOphth FACS) a Founding Member of MeiraGTx and Professor of Ophthalmology, UCL Institute of Ophthalmology in Dept. of Genetics. He is a Consultant Ophthalmologist at Moorfields Eye Hospital in Depts. Of Inherited Eye Disease, Medical Retina and Paediatric Ophthalmology.
MeiraGTX saw statistically significant improvement demonstrated in vision-guided mobility and visual function in treated eyes compared to untreated eyes during its Phase 1/2 clinical trial of AAV-RPE65 in both adult and pediatric patients with RPE65-deficiency.